11/08/2024 3:20 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 9:52 AM | Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024 4:07 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024 3:05 PM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 3:10 PM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024 3:42 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:42 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/01/2024 3:43 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024 3:30 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024 5:43 AM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2024 5:05 AM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:07 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:29 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:30 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:30 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:31 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 7:03 AM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 3:16 PM | Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:23 PM | Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject) Weber Barbara (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:33 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 3:33 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 3:16 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:17 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:17 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:18 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:18 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 6:06 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 5:41 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 5:22 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:37 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:15 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:24 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 3:23 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 3:15 PM | Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 3:48 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:34 PM | Clyburn Frank (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 4:34 PM | Clyburn Frank (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:07 PM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form 424B5 | |
08/02/2024 4:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 3:29 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 4:05 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Breaking News: Tesla headed to $500… (Ad) That headline hit late last night…and the rally has begun
Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. |
07/15/2024 3:27 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 7:03 AM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 3:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:36 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:36 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 3:36 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 3:36 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 3:19 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:19 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024 4:05 PM | Horning Sandra (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024 4:06 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024 4:06 PM | Borisy Alexis (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024 4:07 PM | Kim Lorence H. (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024 4:07 PM | Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer) Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024 4:08 PM | Borellini Flavia (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024 4:09 PM | ANDERSON ELIZABETH M (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4/A | |
06/27/2024 5:48 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:20 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 3:20 PM | ANDERSON ELIZABETH M (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:20 PM | Borellini Flavia (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:20 PM | Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:21 PM | Kim Lorence H. (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:21 PM | Borisy Alexis (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:22 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:23 PM | Horning Sandra (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 10:28 AM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:47 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:37 PM | Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject) Wei Lin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:20 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:08 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 3:56 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 3:31 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:18 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:40 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024 3:31 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 4:11 PM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form S-3ASR | |
05/03/2024 6:36 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 3:30 PM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form DEF 14A | |
04/25/2024 3:35 PM | Revolution Medicines, Inc. (Filer) Revolution Medicines (Filer)
| Form DEFA14A | |
04/12/2024 7:08 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 3:23 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | Patel Sushil (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024 3:57 PM | Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer) Wei Lin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/27/2024 3:24 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:43 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:44 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:44 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad) Now it's your time to return the favor by taking advantage of this tax "revenge loophole."
Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! |
03/20/2024 3:45 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:45 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:50 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:10 PM | Anders Jack (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:21 PM | Cislini Jeff (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:04 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:48 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 3:32 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Issuer) Revolution Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:30 PM | Horn Margaret A (Reporting) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |